Stem Pharm welcomes their newest Advisor, Dr. Edsel Abud

Dr. Edsel Abud has joined Stem Pharm’s talented team of Advisors. While attending University of California Irvine for his MD and PhD as part of the NIH`s Medical Scientist Training Program (MSTP), Dr. Abud notably developed one of the first methods to generate human microglia from stem cells, showing their functional genomics and how they play a role in health and disease. Dr. Abud was also the first to demonstrate that human microglia can develop and engraft in mouse brains. Edsel is currently a KL2 Clinical Scholar at Scripps Translational Institute where he is completing his research track specialty in Allergy and Immunology and an internal medicine residency. His future work will focus on Siglec biology (e.g. CD33) and its regulation of myeloid cell compartments in health and disease.